Results for 'pharmaceuticals'

103 found
Order:
See also
  1. Pharmaceutical risk communication: sources of uncertainty and legal tools of uncertainty management.Barbara Osimani - 2010 - Health Risk and Society 12 (5):453-69.
    Risk communication has been generally categorized as a warning act, which is performed in order to prevent or minimize risk. On the other side, risk analysis has also underscored the role played by information in reducing uncertainty about risk. In both approaches the safety aspects related to the protection of the right to health are on focus. However, it seems that there are cases where a risk cannot possibly be avoided or uncertainty reduced, this is for instance valid for the (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  2. Are pharmaceutical patents protected by human rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
    The International Bill of Rights enshrines a right to health, which includes a right to access essential medicines. This right frequently appears to conflict with the intellectual property regime that governs pharmaceutical patents. However, there is also a human right that protects creative works, including scientific productions. Does this right support intellectual property protections, even when they may negatively affect health? -/- This article examines the recent attempt by the Committee on Economic, Social and Cultural Rights to resolve this issue (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  3. A Defence of Pharmaceutical Paternalism.David Teira - 2020 - Journal of Applied Philosophy 37 (4):528-542.
    Pharmaceutical paternalism is the normative stance upheld by pharmaceutical regulatory agencies like the US Food and Drug Administration. These agencies prevent patients from accessing treatments declared safe and ineffective for the patient’s good without their consent. Libertarian critics of the FDA have shown a number of significant flaws in regulatory paternalism. Against these objections, I will argue that, in order to make an informed decision about treatments, a libertarian patient should request full disclosure of the uncertainty about an experimental treatment. (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  4. Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property.Rivka Amado & Nevin M. Gewertz - 2004 - Journal of Business Ethics 55 (3):295-308.
    The moral justification of intellectual property is often called into question when placed in the context of pharmaceutical patents and global health concerns. The theoretical accounts of both John Rawls and Robert Nozick provide an excellent ethical framework from which such questions can be clarified. While Nozick upholds an individuals right to intellectual property, based upon its conformation with Lockean notions of property and Nozicks ideas of just acquisition and transfer, Rawls emphasizes the importance of basic liberties, such as an (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  5. Understanding the pharmaceutical patent system in Spain and Europe: a perspective from the need to take its protection-access tradeoff seriously.Iván Vargas-Chaves & José López-Oliva - 2020 - In Iván Vargas-Chaves & Daniel Alzate-Mora (eds.), Derecho y Salud: debates contemporáneos. Sincelejo: Editorial CECAR. pp. 73-86.
    As a result of the doctoral research developed by the main author (Vargas-Chaves, 2017), it was identified the evolution and perspectives of the pharmaceutical patent in the international trade system, as well as it future legal research needs in this topic, both immediate and long-term. Furthermore, a number of problems of public health were highlighted in which the patent-term-extension mechanisms have produced a lack of access to medicines.
    Download  
     
    Export citation  
     
    Bookmark  
  6. Libya’s Pharmaceutical Situation: A Professional Opinion.Abdulbaset Elfituri, Asmaa Almoudy, Wafaa Jbouda, Wesal Abuflaiga & Fathi M. Sherif - 2018 - International Journal of Academic Health and Medical Research (IJAHMR) 2 (10):5-9.
    Abstract: To improve the countries’ pharmaceutical situation and to monitor the progress, the World Health Organization (WHO) and member states developed a system of indicators to measure the respective important aspects as a prerequisite step. Level I indicators to assess the country’s pharmaceutical situation include the national drug policy; legislation and regulations; drug accessibility and affordability; essential drug list; quality control; pharmacovigilance; storage and distribution; information and rational use. This study is aimed to document the professional opinion of 20 pharmacy (...)
    Download  
     
    Export citation  
     
    Bookmark  
  7. Are You Morally Modified?: The Moral Effects of Widely Used Pharmaceuticals.Neil Levy, Thomas Douglas, Guy Kahane, Sylvia Terbeck, Philip J. Cowen, Miles Hewstone & Julian Savulescu - 2014 - Philosophy, Psychiatry, and Psychology 21 (2):111-125.
    A number of concerns have been raised about the possible future use of pharmaceuticals designed to enhance cognitive, affective, and motivational processes, particularly where the aim is to produce morally better decisions or behavior. In this article, we draw attention to what is arguably a more worrying possibility: that pharmaceuticals currently in widespread therapeutic use are already having unintended effects on these processes, and thus on moral decision making and morally significant behavior. We review current evidence on the (...)
    Download  
     
    Export citation  
     
    Bookmark   24 citations  
  8. What are the obligations of pharmaceutical companies in a global health emergency?Ezekiel J. Emanuel, Allen Buchanan, Shuk Ying Chan, Cécile Fabre, Daniel Halliday, Joseph Heath, Lisa Herzog, R. J. Leland, Matthew S. McCoy, Ole F. Norheim, Carla Saenz, G. Owen Schaefer, Kok-Chor Tan, Christopher Heath Wellman, Jonathan Wolff & Govind Persad - 2021 - Lancet 398 (10304):1015.
    All parties involved in researching, developing, manufacturing, and distributing COVID-19 vaccines need guidance on their ethical obligations. We focus on pharmaceutical companies' obligations because their capacities to research, develop, manufacture, and distribute vaccines make them uniquely placed for stemming the pandemic. We argue that an ethical approach to COVID-19 vaccine production and distribution should satisfy four uncontroversial principles: optimising vaccine production, including development, testing, and manufacturing; fair distribution; sustainability; and accountability. All parties' obligations should be coordinated and mutually consistent. For (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  9. Moral Obligation of Pharmaceutical Companies towards HIV Victims in Developing Countries.Azam Golam - 2008 - The Dhaka University Studies 64 (1):197-212.
    The objective of the paper is to analyze whether that the pharmaceutical companies producing HIV drugs have moral obligation(s) towards the HIV victims in developing countries who don‟t have access to get drug to reduce their risks. The primary assessment is that the pharmaceutical companies have minimum moral obligation(s) to the HIV patients especially in developing countries. It is because they are human beings and hence they are the subject of moral considerations. The paper argues that from the sense of (...)
    Download  
     
    Export citation  
     
    Bookmark  
  10. Impacts of Cyber Security and Supply Chain Risk on Digital Operations: Evidence from the Pharmaceutical Industry.Federico Del Giorgio Solfa - 2022 - International Journal of Technology Innovation and Management (Ijtim) 2 (2):18-32.
    Purpose: The research explored empirical evidence to assess the impact of cyber security and supply chain risk on digital operations in the UAE pharmaceutical industry. Methodology/Design/Approach: Based on responses from 243 personnel working at 14 pharmaceutical manufacturing companies in Dubai, data were examined for normality, instrument validity and regression analysis. Cyber security and SC risk on digital operations were explored by applying convenient sampling and descriptive and analytical research design. Findings: The findings validated the significant positive association between cyber security (...)
    Download  
     
    Export citation  
     
    Bookmark  
  11. (1 other version)Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society.James M. Huebner - 2014 - Journal of Buisness Ethics (3):1-10.
    Many people believe that the research-based pharmaceutical industry has a ‘special’ moral obligation to provide lifesaving medications to the needy, either free-ofcharge or at a reduced rate relative to the cost of manufacture. In this essay, I argue that we can explain the ubiquitous notion of a special moral obligation as an expression of emotionally charged intuitions involving sacred or protected values and an aversive response to betrayal in an asymmetric trust relationship. I then review the most common arguments used (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  12. Limitless as a neuro-pharmaceutical experiment and as a Daseinsanalyse: on the use of fiction in preparatory debates on cognitive enhancement. [REVIEW]Hub Zwart - 2014 - Medicine, Health Care and Philosophy 17 (1):29-38.
    Limitless is a movie (released in 2011) as well as a novel (published in 2001) about a tormented author who (plagued by a writer’s block) becomes an early user of an experimental designer drug. The wonder drug makes him highly productive overnight and even allows him to make a fortune on the stock market. At the height of his career, however, the detrimental side-effects become increasingly noticeable. In this article, Limitless is analysed from two perspectives. First of all, building on (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  13. The Policy of Functional Integration of the Product Planning Team as a Strategy for the Development of the Pharmaceutical Industry in Palestine.Samer M. Arqawi, Amal A. Al Hila, Samy S. Abu-Naser & Mazen J. Al Shobaki - 2019 - International Journal of Academic Accounting, Finance and Management Research (IJAAFMR) 3 (1):61-69.
    This study presented the policy of functional integration of the product planning team as a strategy for the development of the pharmaceutical industry in Palestine. The study population consists of all the workers in companies operating in the field of medicine in Palestine, which are (5) companies producing in the West Bank only for pharmaceuticals used by these companies, which are (296) employees, and was used a simple random sample to choose the sample and size (87) employees of the (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  14. Ethics and the Pharmaceutical Industry. [REVIEW]Joakim Sandberg - 2010 - European Journal of Health Law 17:211-214.
    Download  
     
    Export citation  
     
    Bookmark  
  15. Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, Michael Kremer and Rachel Glennerster , 152 pp., $24.95 cloth. [REVIEW]Rekha Nath - 2005 - Ethics and International Affairs 19 (3):103-106.
    Download  
     
    Export citation  
     
    Bookmark  
  16. A new direction for science and values.Daniel J. Hicks - 2014 - Synthese 191 (14):3271-95.
    The controversy over the old ideal of “value-free science” has cooled significantly over the past decade. Many philosophers of science now agree that even ethical and political values may play a substantial role in all aspects of scientific inquiry. Consequently, in the last few years, work in science and values has become more specific: Which values may influence science, and in which ways? Or, how do we distinguish illegitimate from illegitimate kinds of influence? In this paper, I argue that this (...)
    Download  
     
    Export citation  
     
    Bookmark   66 citations  
  17. Pricing Medicine Fairly.Robert C. Hughes - 2020 - Philosophy of Management 19 (4):369-385.
    Recently, dramatic price increases by several pharmaceutical companies have provoked public outrage. These scandals raise questions both about how pharmaceutical firms should be regulated and about how pharmaceutical executives ethically ought to make pricing decisions when drug prices are largely unregulated. Though there is an extensive literature on the regulatory question, the ethical question has been largely unexplored. This article defends a Kantian approach to the ethics of pharmaceutical pricing in an unregulated market. To the extent possible, pharmaceutical companies must (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  18. Truthfulness and Business.Lubomira Radoilska - 2008 - Journal of Business Ethics 79 (1-2):21 - 28.
    According to a common assumption, truthfulness cannot have an intrinsic value in business. Instead, it is considered only instrumentally valuable for business, because it contributes to successful trust-building. Some authors deny truthfulness even this limited role by claiming that truth-telling is not an essential part of business, which is a sui generis practice like poker. In this article, I argue that truthfulness has indeed an intrinsic value in business and identify the conceptual confusions underlying the opposite view. My account of (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  19. Is regulatory innovation fit for purpose? A case study of adaptive regulation for advanced biotherapeutics.Giovanni De Grandis - 2022 - Regulation and Governance 16.
    The need to better balance the promotion of scientific and technological innovation with risk management for consumer protection has inspired several recent reforms attempting to make regulations more flexible and adaptive. The pharmaceutical sector has a long, established regulatory tradition, as well as a long history of controversies around how to balance incentives for needed therapeutic innovations and protecting patient safety. The emergence of disruptive biotechnologies has provided the occasion for regulatory innovation in this sector. This article investigates the regulation (...)
    Download  
     
    Export citation  
     
    Bookmark  
  20. (1 other version)The Medicalization of Love.Brian D. Earp, Anders Sandberg & Julian Savulescu - 2015 - Cambridge Quarterly of Healthcare Ethics 24 (3):323-336.
    Pharmaceuticals or other emerging technologies could be used to enhance (or diminish) feelings of lust, attraction, and attachment in adult romantic partnerships. While such interventions could conceivably be used to promote individual (and couple) well-being, their widespread development and/or adoption might lead to “medicalization” of human love and heartache—for some, a source of serious concern. In this essay, we argue that the “medicalization of love” need not necessarily be problematic, on balance, but could plausibly be expected to have either (...)
    Download  
     
    Export citation  
     
    Bookmark   33 citations  
  21. The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct.Leemon McHenry & Jay D. Amsterdam - 2019 - Journal of Scientific Practice and Integrity 1 (1):1-12.
    Medical ghostwriting is the practice in which pharmaceutical companies engage an outside writer to draft a manuscript submitted for publication in the names of “honorary authors,” typically academic key opinion leaders. Using newly-posted documents from paroxetine litigation, we show how the use of ghostwriters and key opinion leaders contributed to the publication of a medical journal article containing manipulated outcome data to favor the proprietary medication. The article was ghostwritten and managed by SmithKline Beecham, now GlaxoSmithKline (GSK) and Scientific Therapeutics (...)
    Download  
     
    Export citation  
     
    Bookmark  
  22. A New Theory of Serendipity: Nature, Emergence and Mechanism.Quan-Hoang Vuong (ed.) - 2022 - Berlin, Germany: De Gruyter.
    When you type the word “serendipity” in a word-processor application such as Microsoft Word, the autocorrection engine suggests you choose other words like “luck” or “fate”. This correcting act turns out to be incorrect. However, it points to the reality that serendipity is not a familiar English word and can be misunderstood easily. Serendipity is a very much scientific concept as it has been found useful in numerous scientific discoveries, pharmaceutical innovations, and numerous humankind’s technical and technological advances. Therefore, there (...)
    Download  
     
    Export citation  
     
    Bookmark   40 citations  
  23. Rationing, Responsibility, and Vaccination during COVID-19: A Conceptual Map.Jin K. Park & Ben Davies - 2023 - American Journal of Bioethics 24 (7):66-79.
    Throughout the COVID-19 pandemic, shortages of scarce healthcare resources consistently presented significant moral and practical challenges. While the importance of vaccines as a key pharmaceutical intervention to stem pandemic scarcity was widely publicized, a sizable proportion of the population chose not to vaccinate. In response, some have defended the use of vaccination status as a criterion for the allocation of scarce medical resources. In this paper, we critically interpret this burgeoning literature, and describe a framework for thinking about vaccine-sensitive resource (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  24. Models, Parameterization, and Software: Epistemic Opacity in Computational Chemistry.Frédéric Wieber & Alexandre Hocquet - 2020 - Perspectives on Science 28 (5):610-629.
    . Computational chemistry grew in a new era of “desktop modeling,” which coincided with a growing demand for modeling software, especially from the pharmaceutical industry. Parameterization of models in computational chemistry is an arduous enterprise, and we argue that this activity leads, in this specific context, to tensions among scientists regarding the epistemic opacity transparency of parameterized methods and the software implementing them. We relate one flame war from the Computational Chemistry mailing List in order to assess in detail the (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  25. Introduction.Thomas Douglas & David Birks - 2018 - In David Birks & Thomas Douglas (eds.), Treatment for Crime: Philosophical Essays on Neurointerventions in Criminal Justice. Oxford: Oxford University Press.
    Crime-preventing neurointerventions (CPNs) are increasingly being used or advocated for crime prevention. There is increasing use of testosterone-lowering agents to prevent recidivism in sexual offenders, and strong political and scientific interest in developing pharmaceutical treatments for psychopathy and anti-social behaviour. Recent developments suggest that we may ultimately have at our disposal a range of drugs capable of suppressing violent aggression, and it is not difficult to imagine possible applications of such drugs in crime prevention. But should neurointerventions be used in (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  26. Disease-mongering through clinical trials.María González-Moreno, Cristian Saborido & David Teira - 2015 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 51:11-18.
    Our goal in this paper is to articulate a precise concept of at least a certain kind of disease-mongering, showing how pharmaceutical marketing can commercially exploit certain diseases when their best definition is given through the success of a treatment in a clinical trial. We distinguish two types of disease-mongering according to the way they exploit the definition of the trial population for marketing purposes. We argue that behind these two forms of disease-mongering there are two well-known problems in the (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  27. Medicalization of Sexual Desire.Jacob Stegenga - 2021 - European Journal of Analytic Philosophy 17 (2):(SI5)5-34.
    Medicalisation is a social phenomenon in which conditions that were once under legal, religious, personal or other jurisdictions are brought into the domain of medical authority. Low sexual desire in females has been medicalised, pathologised as a disease, and intervened upon with a range of pharmaceuticals. There are two polarised positions on the medicalisation of low female sexual desire: I call these the mainstream view and the critical view. I assess the central arguments for both positions. Dividing the two (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  28. The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?Giovanni De Grandis - 2018 - Risk and Regulation Magazine 32 (Winter 2018):20-23.
    The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.
    Download  
     
    Export citation  
     
    Bookmark  
  29. Transsexuality, the Curio, and the Transgender Tipping Point.Amy Marvin - 2020 - In Perry Zurn (ed.), Curiosity Studies: A New Ecology of Knowledge. Minneapolis, MN, USA: University of Minnesota Press. pp. 188-208.
    This essay develops a concept of curiotization, through which people are reduced to a curio for the fascination of others. I argue that trans people as they have appeared in media, philosophy, and narratives of history are curiotized as forever fascinating, new, titillating, and controversial. In contrast to the narrative of momentous trans progress in the mid-2010s, I point out that frameworks such as the "Transgender Tipping Point" worked to position its "trans moment" as unprecedented and always on the threshold (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  30. Justice in epistemic gaps: The ‘proof paradox’ revisited.Lewis Ross - 2021 - Philosophical Issues 31 (1):315-333.
    This paper defends the heretical view that, at least in some cases, we ought to assign legal liability based on purely statistical evidence. The argument draws on prominent civil law litigation concerning pharmaceutical negligence and asbestos-poisoning. The overall aim is to illustrate moral pitfalls that result from supposing that it is never appropriate to rely on bare statistics when settling a legal dispute.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  31. Moral Enhancement Can Kill.Parker Crutchfield - 2018 - Journal of Medicine and Philosophy 43 (5):568-584.
    There is recent empirical evidence that personal identity is constituted by one’s moral traits. If true, this poses a problem for those who advocate for moral enhancement, or the manipulation of a person’s moral traits through pharmaceutical or other biological means. Specifically, if moral enhancement manipulates a person’s moral traits, and those moral traits constitute personal identity, then it is possible that moral enhancement could alter a person’s identity. I go a step further and argue that under the right conditions, (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  32. Exploring Regulatory Flexibility to Create Novel Incentives to Optimize Drug Discovery.Jacqueline A. Sullivan & E. Richard Gold - 2024 - Frontiers in Medicine 11 (Section on Regulatory Science).
    Efforts by governments, firms, and patients to deliver pioneering drugs for critical health needs face a challenge of diminishing efficiency in developing those medicines. While multi-sectoral collaborations involving firms, researchers, patients, and policymakers are widely recognized as crucial for countering this decline, existing incentives to engage in drug development predominantly target drug manufacturers and thereby do little to stimulate collaborative innovation. In this mini review, we consider the unexplored potential within pharmaceutical regulations to create novel incentives to encourage a diverse (...)
    Download  
     
    Export citation  
     
    Bookmark  
  33. The Influence of Values on Medical Research.S. Andrew Schroeder - forthcoming - In Alex Broadbent (ed.), Oxford Handbook of Philosophy of Medicine. Oxford University Press.
    Mainstream views of medical research tell us it should be a fact-based, value-free endeavor: what a scientist (or her funding source) wants or cares about should not influence her findings. At the same time, we also sometimes criticize medical research for failing to embody certain values, e.g. when we criticize pharmaceutical companies for largely ignoring the diseases that affect the global poor. This chapter seeks to reconcile these perspectives by distinguishing appropriate from inappropriate influences of values on medical research. It (...)
    Download  
     
    Export citation  
     
    Bookmark  
  34. Blood Products and the Commodification Debate: The Blurry Concept of Altruism and the ‘Implicit Price’ of Readily Available Body Parts.Annette Dufner - 2015 - HEC Forum 27 (4):347-359.
    There is a widespread consensus that a commodification of body parts is to be prevented. Numerous policy papers by international organizations extend this view to the blood supply and recommend a system of uncompensated volunteers in this area—often, however, without making the arguments for this view explicit. This situation seems to indicate that a relevant source of justified worry or unease about the blood supply system has to do with the issue of commodification. As a result, the current health minister (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  35. Biological Interventions for Crime Prevention.Christopher Chew, Thomas Douglas & Nadira Faber - 2018 - In David Birks & Thomas Douglas (eds.), Treatment for Crime: Philosophical Essays on Neurointerventions in Criminal Justice. Oxford: Oxford University Press.
    This chapter sets the scene for the subsequent philosophical discussions by surveying a number of biological interventions that have been used, or might in the future be used, for the purposes of crime prevention. These interventions are pharmaceutical interventions intended to suppress libido, treat substance abuse or attention deficit-hyperactivity disorder (ADHD), or modulate serotonin activity; nutritional interventions; and electrical and magnetic brain stimulation. Where applicable, we briefly comment on the historical use of these interventions, and in each case we discuss (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  36. Drug Regulation and the Inductive Risk Calculus.Jacob Stegenga - 2017 - In Kevin Christopher Elliott & Ted Richards (eds.), Exploring Inductive Risk: Case Studies of Values in Science. New York: Oup Usa. pp. 17-36.
    Drug regulation is fraught with inductive risk. Regulators must make a prediction about whether or not an experimental pharmaceutical will be effective and relatively safe when used by typical patients, and such predictions are based on a complex, indeterminate, and incomplete evidential basis. Such inductive risk has important practical consequences. If regulators reject an experimental drug when it in fact has a favourable benefit/harm profile, then a valuable intervention is denied to the public and a company’s material interests are needlessly (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  37. Adapt to Translate – Adaptive Clinical Trials and Biomedical Innovation.Daria Jadreškić - 2021 - European Journal of Analytic Philosophy 17 (2):(SI3)5-24.
    The article presents the advantages and limitations of adaptive clinical trials for assessing the effectiveness of medical interventions and specifies the conditions that contributed to their development and implementation in clinical practice. I advance two arguments by discussing different cases of adaptive trials. The normative argument is that responsible adaptation should be taken seriously as a new way of doing clinical research insofar as a valid justification, sufficient understanding, and adequate operational conditions are provided. The second argument is historical. The (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  38. The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic.Mariana Barosa, Euzebiusz Jamrozik & Vinay Prasad - 2023 - Medicine, Health Care and Philosophy (1):49-70.
    In times of crises, public health leaders may claim that trials of public health interventions are unethical. One reason for this claim can be that equipoise—i.e. a situation of uncertainty and/or disagreement among experts about the evidence regarding an intervention—has been disturbed by a change of collective expert views. Some might claim that equipoise is disturbed if the majority of experts believe that emergency public health interventions are likely to be more beneficial than harmful. However, such beliefs are not always (...)
    Download  
     
    Export citation  
     
    Bookmark  
  39. Global Bioethics and Political Theory.Joseph Millum - 2012 - In J. Millum & E. J. Millum (eds.), Global Justice and bioethics. Oxford University Press. pp. 17-42.
    Most bioethicists who address questions to which global justice matters have not considered the significance of the disputes over the correct theory of global justice. Consequently, the significance of the differences between theories of global justice for bioethics has been obscured. In this paper, I consider when and how these differences are important. I argue that certain bioethical problems can be resolved without addressing disagreements about global justice. People with very different views about global justice can converge on the existence (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  40. Psychedelics and Critical Theory: individualization and alienation in psychedelic psychotherapy.Julien Tempone Wiltshire & Traill Dowie - 2023 - Journal of Psychedelic Studies 7 (3):161–173.
    In the monograph Philosophy and Psychedelics: Frameworks for Exceptional Experience, Hauskeller raises the important subject of individualization and alienation in psychedelic psychotherapy. Under the prevailing conditions of neoliberalism, Hauskeller contends that psychedelic-assisted psychotherapy appropriates Indigenous knowledges in an oppressive fashion, may be instrumentalised to the ends of productivity gain and symptom suppression, and may be utilised to mask societal systems of alienation. Whilst offering a valuable socio-political critique of psychedelics' clinical uptake, we suggest that Hauskeller's view does not adequately acknowledge (...)
    Download  
     
    Export citation  
     
    Bookmark  
  41. Exercise Prescription and The Doctor's Duty of Non-Maleficence.Jonathan Pugh, Christopher Pugh & Julian Savulesu - 2017 - British Journal of Sports Medicine 51 (21):1555-1556.
    An abundance of data unequivocally shows that exercise can be an effective tool in the fight against obesity and its associated co-morbidities. Indeed, physical activity can be more effective than widely-used pharmaceutical interventions. Whilst metformin reduces the incidence of diabetes by 31% (as compared with a placebo) in both men and women across different racial and ethnic groups, lifestyle intervention (including exercise) reduces the incidence by 58%. In this context, it is notable that a group of prominent medics and exercise (...)
    Download  
     
    Export citation  
     
    Bookmark  
  42. Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines.Katja Voit, Cristian Timmermann, Marcin Orzechowski & Florian Steger - 2023 - Frontiers in Public Health 11:995683.
    Introduction: There is currently no binding, internationally accepted and successful approach to ensure global equitable access to healthcare during a pandemic. The aim of this ethical analysis is to bring into the discussion a legally regulated vaccine allocation as a possible strategy for equitable global access to vaccines. We focus our analysis on COVAX (COVID-19 Vaccines Global Access) and an existing EU regulation that, after adjustment, could promote global vaccine allocation. -/- Methods: The main documents discussing the two strategies are (...)
    Download  
     
    Export citation  
     
    Bookmark  
  43. Research ethics: Ethics and methods in surgical trials.C. Ashton, N. Wray, A. Jarman, J. Kolman & D. Wenner - 2009 - Journal of Medical Ethics 35 (9):579-583.
    This paper focuses on invasive therapeutic procedures, defined as procedures requiring the introduction of hands, instruments, or devices into the body via incisions or punctures of the skin or mucous membranes performed with the intent of changing the natural history of a human disease or condition for the better. Ethical and methodological concerns have been expressed about studies designed to evaluate the effects of invasive therapeutic procedures. Can such studies meet the same standards demanded of those, for example, evaluating pharmaceutical (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  44. From ‘Hard’ Neuro-Tools to ‘Soft’ Neuro-Toys? Refocussing the Neuro-Enhancement Debate.Jonna Brenninkmeijer & Hub Zwart - 2016 - Neuroethics 10 (3):337-348.
    Since the 1990’s, the debate concerning the ethical, legal and societal aspects of ‘neuro-enhancement’ has evolved into a massive discourse, both in the public realm and in the academic arena. This ethical debate, however, tends to repeat the same sets of arguments over and over again. Normative disagreements between transhumanists and bioconservatives on invasive or radical brain stimulators, and uncertainties regarding the use and effectivity of nootropic pharmaceuticals dominate the field. Building on the results of an extensive European project (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  45. Equipoise, standard of care, and consent: Responding to the authorisation of new COVID-19 treatments in randomised controlled trials.Soren Holm, Jonathan Lewis & Rafael Dal-Ré - 2022 - Journal of Medical Ethics:1-6.
    In response to the COVID-19 pandemic, large-scale research and pharmaceutical regulatory processes have proceeded at a dramatically increased pace with new and effective, evidence-based COVID-19 interventions rapidly making their way into the clinic. However, the swift generation of high-quality evidence and the efficient processing of regulatory authorisation have given rise to more specific and complex versions of well-known research ethics issues. In this paper, we identify three such issues by focusing on the authorisation of Molnupiravir, a novel antiviral medicine aimed (...)
    Download  
     
    Export citation  
     
    Bookmark  
  46. Synthetic Biology and Biofuels.Catherine Kendig - 2012 - In Paul B. Thompson & David M. Kaplan (eds.), Encyclopedia of Food and Agricultural Ethics. New York: Springer Verlag.
    Synthetic biology is a field of research that concentrates on the design, construction, and modification of new biomolecular parts and metabolic pathways using engineering techniques and computational models. By employing knowledge of operational pathways from engineering and mathematics such as circuits, oscillators, and digital logic gates, it uses these to understand, model, rewire, and reprogram biological networks and modules. Standard biological parts with known functions are catalogued in a number of registries (e.g. Massachusetts Institute of Technology Registry of Standard Biological (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  47. Tác động của chất lượng dịch vụ phân phối đến sự hài lòng khách hàng: Nghiên cứu trong ngành dược phẩm.Hoàng Thị Cúc & Đào Minh Anh - 2024 - Kinh Tế Và Dự Báo.
    Bài viết tập trung vào nghiên cứu tác động của chất lượng dịch vụ phân phối đến sự hài lòng khách hàng doanh nghiệp trong ngành dược phẩm. Nghiên cứu sử dụng 5 nhân tố của chất lượng dịch vụ trong mô hình SERVQUAL và Sự hài lòng khách hàng (B2B) đối với dịch vụ phân phối dược phẩm của các doanh nghiệp cung cấp dược phẩm tại Việt Nam. Nghiên cứu kết hợp phương pháp nghiên cứu định tính và (...)
    Download  
     
    Export citation  
     
    Bookmark  
  48.  93
    The mechanism of action in a spontaneous resolution of chronic depression, anxiety, and burnout—a retrospective case study.Mika Turkia - manuscript
    There is currently no generally agreed-upon definition of the mechanism of action of psychedelic therapy. Existing proposals have approached the issue from various perspectives, utilizing concepts on many layers of abstraction. Most commonly, mechanisms based on neurotransmitters have been proposed. From a clinical perspective, explanations on the psychological level would be more useful. This study provides one such explanation, focusing on the destabilization of trauma-related memories and their replacement with memories that allow for more adaptive behaviors. This mechanism is not (...)
    Download  
     
    Export citation  
     
    Bookmark  
  49.  82
    The commercialization of patient data in Canada: ethics, privacy and policy.Sheryl Spithoff, Jessica Stockdale, Robyn Rowe, Brenda McPhail & Nav Persaud - 2022 - Canadian Medical Association Journal 194 (3).
    KEY POINTS In Canada, commercial data brokers collect deidentified patient data from pharmacies, private drug insurers, the federal government and medical clinics without patient consent. Although pharmaceutical companies are the data brokers’ primary customers, academics and nonprofit and public entities also use commercial data sets, given the absence of a coordinated public approach to collecting these data across Canada. Risks of commercialized patient data include loss of anonymity, surveillance and marketing, discrimination and violation of Indigenous data sovereignty. Coordinated infrastructure for (...)
    Download  
     
    Export citation  
     
    Bookmark  
  50. Drivers of organizational creativity.Mats Sundgren, Elof Dimenäs, Jan-Eric Gustafsson & Marcus Selart - 2005 - RandD Management 35:359-374.
    A path model of organizational creativity was presented; it conceptualized the influences of information sharing, learning culture, motivation, and networking on creative climate. A structural equation model was fitted to data from the pharmaceutical industry to test the proposed model. The model accounted for 86% of the variance in the creative climate dependent variable. Information sharing had a positive effect on learning culture, which in turn had a positive effect on creative climate, while there were negative direct effects of information (...)
    Download  
     
    Export citation  
     
    Bookmark  
1 — 50 / 103